BML Capital Management »

Aadi Bioscience shares owned by BML Capital Management

Quarter-by-quarter ownership of Aadi Bioscience (AADI) shares owned by BML Capital Management from 13F filings

Historical chart of BML Capital Management investment in Aadi Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Aadi Bioscience held by BML Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aadi Bioscience by BML Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.1M 2.0M 2.06

More positions owned by BML Capital Management

Ishares Tr 0-3 Mnth Treasry (SGOV)
Instil Bio Com New (TIL)
Atea Pharmaceuticals (AVIR)
Aclaris Therapeutics (ACRS)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Adverum Biotechnologies Com New (ADVM)
Tectonic Therapeutic (TECX)
An2 Therapeutics (ANTX)
Reneo Pharmaceuticals (RPHM)
Oramed Pharmaceuticals Com New (ORMP)
Achilles Therapeutics Sponsored Ads (ACHL)
Aadi Bioscience (AADI)
Connect Biopharma Hldgs Ads (CNTB)
Pmv Pharmaceuticals (PMVP)
Astrotech Corp (ASTC)

View all positions for BML Capital Management

Top funds holding Aadi Bioscience

BML Capital Management
Vanguard Group
Renaissance Technologies
Acuitas Investments
Soleus Capital Management
BlackRock
BlackRock
Geode Capital Management
Goldman Sachs Group
Verition Fund Management
Susquehanna International
State Street Corporation
Northern Trust
Morgan Stanley
Marquette Asset Management

View all funds holding Aadi Bioscience